Deerfield Management Company, L.P. (Series C) Oncology Institute, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.76 Billion
- Q2 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,360,052 shares of TOI stock, worth $940,814. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,360,052
Previous 3,360,052
-0.0%
Holding current value
$940,814
Previous $5.31 Million
70.89%
% of portfolio
0.03%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding TOI
# of Institutions
40Shares Held
14.1MCall Options Held
83.9KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.78MShares$499,3670.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.75MShares$490,0000.37% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.73MShares$483,1570.0% of portfolio
-
Tiff Advisory Services Inc1.42MShares$397,2310.22% of portfolio
-
Triatomic Management LP New York, NY803KShares$224,83010.89% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $20.6M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...